Saturday, April 19, 2014   

Nine child deaths of 17 not linked to BioKangtai vaccines
(01-03 14:11)

Authorities in China have not found a link between the Hepatitis B vaccines given to nine children and their deaths.
There have been 17 deaths following the administering of Shenzhen biotech company BioKangtai's vaccinations between December 13 and 31. All have been investigated or are under investigation.
Nine of the cases have nothing to do with the vaccines, director of the disease control bureau of the National Health and Family Planning Commission Yu Jingjin told a press conference.
Preliminary analysis of the eight other cases have not indicated a link between the deaths and vaccines, but the cause of the deaths will be confirmed only after autopsies, Yu said.
Also at the press conference, Li Guoqing of the China Food and Drug Administration, said no problems had been found with BioKangtai vaccines in production practices or product quality. --Xinhua
   
Other China breaking news:
Blogger jailed in online 'rumour' crackdown (04-17 12:22)
More dead pigs found in Qinghai river: report (04-17 12:14)
3 dead, 5 missing in Jiangsu chemical plant blast (04-16 18:12)
Mainland open to cross-Strait leaders summit (04-16 17:55)
Captain America tops China box office (04-15 19:06)
Tap water company denies pollution cover-up (04-15 13:15)
Tsai sole candidate for DPP leadership race (04-14 19:06)
Taiwanese tourists injured in Japan deer rampage (04-14 12:29)
Officials seek to block corruption protesters: report (04-14 12:12)
Activist appeal rejected (04-11 11:00)

More breaking news >>

© 2014 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2014, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.